Neogenomics (NEO) Treasury Shares (2011 - 2026)

Neogenomics (NEO) has reported Treasury Shares for 16 consecutive years, with $3.7 million the latest figure, recorded in Q1 2026.

• Treasury Shares for Q1 2026 came in at $3.7 million, up 7.62% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.7 million (up 7.62% YoY), and the FY2025 annual result was $552208.0, down 74.48% from the prior year.
• Treasury Shares was $3.7 million for Q1 2026 at Neogenomics, up from $552208.0 in the prior quarter.
• Over five years, Treasury Shares peaked at $3.7 million in Q1 2026 and troughed at $305105.0 in Q3 2023.
• Average Treasury Shares over 5 years is $2.0 million, with a median of $2.1 million recorded in 2023.
• Year-over-year, Treasury Shares slumped 84.71% in 2023 and jumped 366.55% in 2025.
• Over 5 years, Treasury Shares stood at $2.0 million in 2022, then declined by 1.65% to $2.0 million in 2023, then advanced by 10.3% to $2.2 million in 2024, then sank by 74.48% to $552208.0 in 2025, then surged by 575.1% to $3.7 million in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $3.7 million in Q1 2026, $552208.0 in Q4 2025, and $3.0 million in Q3 2025.